AI News NQ Analysis

Medical image processing software 'Holoeyes MD' certified under Tokyo Metropolitan Government's FY2026 Trial Order Program

NQ Score 100/100

AI Summary (NQ-processed)

Holoeyes Inc.'s medical XR metaverse system, 'Holoeyes MD' (medical image processing software for general-purpose image diagnostic workstation), has been certified under the Tokyo Metropolitan Government's FY2026 Trial Order Program. This system converts medical images from CT/MRI into 3D models within a metaverse space, making volumetric information visible that is difficult to convey on flat screens, aiding in surgical planning, simulation, and medical education. Holoeyes MD aims to transform implicit knowledge in medical fields into explicit knowledge, thereby improving the quality, safety, and efficiency of healthcare.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What medical software did Holoeyes Inc. develop for the FY2026 Trial Order Program?
A: Holoeyes Inc. developed 'Holoeyes MD', a medical XR metaverse system for processing CT/MRI images into 3D models.
Q: Which government program certified Holoeyes MD in 2026?
A: Holoeyes MD was certified under the Tokyo Metropolitan Government's FY2026 Trial Order Program.
Q: How does Holoeyes MD improve surgical planning compared to traditional screens?
A: Holoeyes MD converts CT/MRI images into 3D metaverse models, making volumetric data visible beyond flat screen limitations.
Q: What year does the 'FY2026' in the Tokyo Metropolitan Government program refer to?
A: The 'FY2026' refers to the Japanese fiscal year 2026, which begins in April 2026 and ends in March 2027.
Q: What type of medical images can Holoeyes MD process for 3D visualization?
A: Holoeyes MD can process CT and MRI medical images to generate 3D models within a metaverse environment.